Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Zosano Pharma (ZSAN)

Zosano Pharma (ZSAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,734
  • Shares Outstanding, K 4,902
  • Annual Sales, $ 790 K
  • Annual Income, $ -29,930 K
  • 60-Month Beta 3.30
  • Price/Sales 3.25
  • Price/Cash Flow N/A
  • Price/Book 0.19
Trade ZSAN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -14.86
  • Most Recent Earnings -7.86 on 05/13/22
  • Next Earnings Date 05/11/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -2.45
  • Growth Rate Est. (year over year) +40,875.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4600 +21.22%
on 06/10/22
2.1993 -74.65%
on 05/20/22
-1.2324 (-68.85%)
since 05/10/22
3-Month
0.4600 +21.22%
on 06/10/22
10.0835 -94.47%
on 03/24/22
-5.2384 (-90.38%)
since 03/10/22
52-Week
0.4600 +21.22%
on 06/10/22
37.4500 -98.51%
on 06/15/21
-32.0554 (-98.29%)
since 06/10/21

Most Recent Stories

More News
Zosano Pharma Reports First Quarter 2022 Financial Results

FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Corporation (ZSAN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Zosano Pharma Corporation (ZSAN) closed at $1.70, marking a +0.59% move from the previous day.

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Provides Corporate Update

FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a...

ZSAN : 0.5576 (+7.23%)
Zosano (ZSAN) to Report Q1 Earnings: What's in the Cards?

Zosano (ZSAN) is set to provide updates on the development path ahead for its lead candidate, M207, when it reports earnings results for first-quarter 2022.

BIIB : 196.81 (-0.49%)
ZSAN : 0.5576 (+7.23%)
AXLA : 1.6100 (-0.62%)
APLT : 0.9183 (-4.34%)
Why Is CarMax (KMX) Stock Down Today?

KMX's used car sales dropped

KMX : 80.30 (+1.02%)
ZSAN : 0.5576 (+7.23%)
DB : 8.15 (-2.28%)
Is Zosano Pharma (ZSAN) Stock Really Up 3,000% Today?

Zosano implemented a reverse stock split in order to stay compliant with the Nasdaq's rules

ZSAN : 0.5576 (+7.23%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

ZSAN and HOTH are leading our lists this morning

PTE : 0.7223 (-2.84%)
AGLE : 0.4340 (-1.68%)
BDSX : 1.2800 (unch)
VERU : 10.76 (+5.28%)
ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Reverse Stock Split Effective Today

ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results

FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)
Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced...

ZSAN : 0.5576 (+7.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe...

See More

Key Turning Points

3rd Resistance Point 0.8167
2nd Resistance Point 0.7259
1st Resistance Point 0.6417
Last Price 0.5576
1st Support Level 0.4667
2nd Support Level 0.3759
3rd Support Level 0.2917

See More

52-Week High 37.4500
Fibonacci 61.8% 23.3198
Fibonacci 50% 18.9550
Fibonacci 38.2% 14.5902
Last Price 0.5576
52-Week Low 0.4600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar